SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-550259
Filing Date
2016-04-21
Accepted
2016-04-21 16:12:13
Documents
3
Period of Report
2016-06-02
Effectiveness Date
2016-04-21

Document Format Files

Seq Description Document Type Size
1 DEF 14A d170601ddef14a.htm DEF 14A 264609
2 GRAPHIC g170601img1.jpg GRAPHIC 217379
3 GRAPHIC g170601img2.jpg GRAPHIC 96044
  Complete submission text file 0001193125-16-550259.txt   689613
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36500 | Film No.: 161584185
SIC: 2834 Pharmaceutical Preparations